Art

J-GLOBAL ID：202002261631786716   Reference number：20A2286015

Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned

COVID-19パンデミック中の血液学的悪性腫瘍患者の管理: 実践的考察と学んだ教訓【JST・京大機械翻訳】

Author (5)： Isidori Alessandro (Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy) ,  de Leval Laurence (Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland) ,  Gergis Usama (Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States) ,  Musto Pellegrino (Unit of Hematology and Stem Cell Transplantation, Department of Emergency and Organ Transplantation, “Aldo Moro” University School of Medicine, AOU Consorziale Policlinico, Bari, Italy) ,  Porcu Pierluigi (Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States)
Material： Frontiers in Oncology (Web)
Volume： 10  Page： 1439  Publication year： 2020 
JST Material Number： U7089A  ISSN： 2234-943X  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： The COVID-19 pandemic has crea...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2286015&from=J-GLOBAL&jstjournalNo=U7089A") }}

Thesaurus term： consolidation(ground) ,  trip ,  *vaccine ,  availability ,  multiplex ,  Europe ,  T cell ,  lymphopenia ,  therapeutic planning
Semi thesaurus term： *悪性腫瘍 ,  骨髄抑制 ,  癌患者 , 【Automatic Indexing@JST】

Author keywords (8)： SARS-CoV-2 ,  hematologic malignancies ,  COVID-19 ,  lymphoma ,  myeloma ,  leukemia ,  CAR T-cell ,  telehealth

JST classification (1)： Blood cell tumors(=neoplasms)  (GK04000M)

Reference (55)：

• Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:727-33. doi: 10.1056/NEJMoa2001017
• Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. (2020) 382:1708-20. doi: 10.1101/2020.02.06.20020974
• Maschmeyer G, De Greef J, Mellinghoff SC, Nosari A, Thiebaut-Bertrand A, Bergeron A, et al. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. a position paper by the European Conference On Infections In Leukemia (ECIL). Leukemia. (2019) 33:844-62. doi: 10.1038/s41375-019-0388-x
• Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. (2020) 21:335-7. doi: 10.1016/S1470-2045(20)30096-6
• He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, et al. COVID-19 in persons with haematological cancers. Leukemia. (2020) 34:1637-45 doi: 10.1038/s41375-020-0836-7

Terms in the title (5)： パンデミック ,  血液学 ,  悪性腫瘍 ,  患者 ,  学んだ教訓